Association between Lower Extremity Skeletal Muscle Mass and Impaired Cognitive Function in Type 2 Diabetes.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
19 02 2020
Historique:
received: 29 08 2019
accepted: 04 02 2020
entrez: 21 2 2020
pubmed: 23 2 2020
medline: 21 11 2020
Statut: epublish

Résumé

Lower extremity skeletal muscle mass (LESM) in Type 2 Diabetes (T2D) has been linked to adverse clinical events, but it is not known whether it is associated with cognitive difficulties. We conducted a cross-sectional study on 1,235 people (mean age 61.4 ± 8.0 years) with T2D under primary and secondary care in Singapore. Bioelectrical impedance analyses (BIA) measures of upper extremity skeletal muscle mass (UESM), LESM and appendicular skeletal muscle index (SMI) were related to the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) measures of cognition, in multiple linear regression. In multivariable models, tertile 1 LESM (b = -2.62 (-3.92 to -1.32)) and tertile 2 LESM (b = -1.73 (-2.73 to -0.73)), referenced to tertile 3) were significantly associated with decreased RBANS total score. Significant associations of LESM with cognitive domain performances were observed for tertile 1 (b = -3.75 (-5.98 to -1.52)) and tertile 2 (b = -1.98 (-3.69 to -0.27)) with immediate memory, and for tertile 1 (b = -3.05 (-4.86 to -1.24)) and tertile 2 (b = -1.87 (-3.25 to -0.48)) with delayed memory, and for tertile 1 (b = -2.99 (-5.30 to -0.68)) with visuospatial/constructional ability. Tertile 1 SMI (b = -1.94 (-3.79 to -0.08) and tertile 2 SMI (b = -1.75 (-3.14 to -0.37)) were also associated with delayed memory. There were no associations between UESM with cognitive performance. Lower LESM may be a useful marker of possible co-occuring cognitive dysfunction.

Identifiants

pubmed: 32076075
doi: 10.1038/s41598-020-59914-3
pii: 10.1038/s41598-020-59914-3
pmc: PMC7031513
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2956

Références

Buch, A. et al. Muscle function and fat content in relation to sarcopenia, obesity and frailty of old age–An overview. Exp. Gerontol. 76, 25–32 (2016).
pubmed: 26785313 doi: 10.1016/j.exger.2016.01.008 pmcid: 26785313
Chang, K. V., Hsu, T. H., Wu, W. T., Huang, K. C. & Han, D. S. Association Between Sarcopenia and Cognitive Impairment: A Systematic Review and Meta-Analysis. J. Am. Med. Dir. Assoc. 17, 1164.e1167–1164.e1115 (2016).
Baumgartner, R. N. et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am. J. Epidemiol. 147, 755–763 (1998).
pubmed: 9554417 doi: 10.1093/oxfordjournals.aje.a009520 pmcid: 9554417
Cawthon, P. M. et al. Do muscle mass, muscle density, strength, and physical function similarly influence risk of hospitalization in older adults? J. Am. Geriatr. Soc. 57, 1411–1419 (2009).
pubmed: 19682143 pmcid: 3269169 doi: 10.1111/j.1532-5415.2009.02366.x
Cesari, M. et al. Skeletal muscle and mortality results from the InCHIANTI Study. J. Gerontol. A Biol. Sci. Med. 64, 377–384 (2009).
doi: 10.1093/gerona/gln031
Huang, C. Y. et al. Association of Dynapenia, Sarcopenia, and Cognitive Impairment Among Community-Dwelling Older Taiwanese. Rejuvenation Res. 19, 71–78 (2016).
pubmed: 26165544 doi: 10.1089/rej.2015.1710 pmcid: 26165544
Abellan van Kan, G. et al. Sarcopenia and cognitive impairment in elderly women: results from the EPIDOS cohort. Age Ageing 42, 196–202 (2013).
pubmed: 23221099 doi: 10.1093/ageing/afs173 pmcid: 23221099
Abellan van Kan, G. et al. Gait speed, body composition, and dementia. The EPIDOS-Toulouse cohort. J. Gerontol. A Biol. Sci. Med. Sci 67, 425–432 (2012).
pubmed: 21975092 doi: 10.1093/gerona/glr177 pmcid: 21975092
Hsu, Y. H. et al. Association of cognitive impairment, depressive symptoms and sarcopenia among healthy older men in the veterans retirement community in southern Taiwan: a cross-sectional study. Geriatr. Gerontol. Int. 14(Suppl 1), 102–108 (2014).
pubmed: 24450567 doi: 10.1111/ggi.12221 pmcid: 24450567
Nishiguchi, S. et al. Sarcopenia as a Risk Factor for Cognitive Deterioration in Community-Dwelling Older Adults: A 1-Year Prospective Study. J. Am. Med. Dir. Assoc. 17(372), e375–378 (2016).
Tolea, M. I. & Galvin, J. E. Sarcopenia and impairment in cognitive and physical performance. Clin. Interv. Aging 10, 663–671 (2015).
pubmed: 25878493 pmcid: 4388078 doi: 10.2147/CIA.S76275
van Kan, G. A. et al. Association of a 7-year percent change in fat mass and muscle mass with subsequent cognitive dysfunction: the EPIDOS-Toulouse cohort. J. Cachexia Sarcopenia Muscle 4, 225–229 (2013).
pubmed: 23888380 doi: 10.1007/s13539-013-0112-z pmcid: 23888380
Hernandez-Ochoa, E.O. & Vanegas, C. Diabetic Myopathy and Mechanisms of Disease. Biochem Pharmacol (Los Angel) open access 4, (2015)
Dennison, E. M., Sayer, A. A. & Copper, C. Epidemiology of sarcopenia and insights into possible therapeutic targets. Nat. Rev. Rheumatol. 13, 340–347 (2017).
pubmed: 28469267 doi: 10.1038/nrrheum.2017.60 pmcid: 28469267
Hamasaki, H. Lower Extremity Skeletal Muscle Mass, but Not Upper Extremity Skeletal Muscle Mass, Is Inversely Associated with Hospitalization in Patients with Type 2 Diabetes. J Diabetes Res 2303467, https://doi.org/10.1155/2017/2303467 (2017)
doi: 10.1155/2017/2303467
Hamasaki, H. et al. Associations between lower extremity muscle mass and metabolic parameters related to obesity in Japanese obese patients with type 2 diabetes. PeerJ 3, e942, https://doi.org/10.7717/peerj.942 (2015).
doi: 10.7717/peerj.942 pubmed: 26175963 pmcid: 4499465
Heitmann, B. L. & Frederiksen, P. Thigh circumference and risk of heart disease and premature death: prospective cohort study. Br. Med. J. 339, b3292, https://doi.org/10.1136/bmi.b3292 (2009).
doi: 10.1136/bmi.b3292
Levey, A. S. et al. A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 150, 604–612 (2009).
pubmed: 19414839 pmcid: 2763564 doi: 10.7326/0003-4819-150-9-200905050-00006
Nyunt, M. S., Fones, C., Niti, M. & Ng, T. P. Criterion-based validity and reliability of the Geriatric Depression Screening Scale (GDS-15) in a large validation sample of community-living Asian older adults. Aging Ment. Health 13, 376–382 (2009).
pubmed: 19484601 doi: 10.1080/13607860902861027 pmcid: 19484601
Kemmler, W. et al. Prevalence of sarcopenia and sarcopenic obesity in older German men using recognized definitions: high accordance but low overlap! Osteoporos. Int. 28, 1881–1891 (2017).
pubmed: 28220197 doi: 10.1007/s00198-017-3964-9 pmcid: 28220197
Chen, L. K. et al. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J. Am. Med. Dir. Assoc. 15, 95–101 (2014).
pubmed: 24461239 doi: 10.1016/j.jamda.2013.11.025 pmcid: 24461239
Collinson, S. L., Fang, S. H., Lim, M. L., Feng, L. & Ng, T. P. Normative data for the repeatable battery for the assessment of neuropsychological status in elderly Chinese. Arch. Clin. Neuropsychol. 29, 442–455 (2014).
pubmed: 24903208 doi: 10.1093/arclin/acu023 pmcid: 24903208
Phillips, R., Cheung, Y. B. & Collinson, S. L. The Equivalence and Difference between the English and Chinese Language Versions of the Repeatable Battery for the Assessment of Neuropsychological Status. Clin. Neuropsychol. 29(Suppl 1), 1–18 (2015).
pubmed: 25922131 doi: 10.1080/13854046.2015.1034182 pmcid: 25922131
Randolph, C., Tierney, M. C., Mohr, E. & Chase, T. N. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity. J. Clin. Exp. Neuropsychol. 20, 310–319 (1998).
pubmed: 9845158 doi: 10.1076/jcen.20.3.310.823 pmcid: 9845158
Cetinus, E., Buyukbese, M. A., Uzel, M., Ekerbicer, H. & Karaoguz, A. Handgrip strength in patients with type 2 diabetes mellitus. Diab Res. Clin. Pract. 70, 278–286 (2005).
doi: 10.1016/j.diabres.2005.03.028
Bianchi, L. & Volpato, S. Muscle dysfunction in type 2 diabetes: a major threat to patient’s mobility and independence. Acta Diabetol. 53, 879–889 (2016).
pubmed: 27393005 doi: 10.1007/s00592-016-0880-y pmcid: 27393005
Bordier, L., Doucet, J., Boudet, J. & Bauduceau, B. Update on cognitive decline and dementia in elderly patients with diabetes. Diabetes Metab. 40, 331–337 (2014).
pubmed: 24703603 doi: 10.1016/j.diabet.2014.02.002 pmcid: 24703603
Cukierman, T., Gerstein, H. C. & Williamson, J. D. Cognitive decline and dementia in diabetes–systematic overview of prospective observational studies. Diabetologia 48, 2460–2469 (2005).
pubmed: 16283246 doi: 10.1007/s00125-005-0023-4 pmcid: 16283246
Farris, W. et al. Partial loss-of-function mutations in insulin-degrading enzyme that induce diabetes also impair degradation of amyloid beta-protein. Am. J. Pathol. 164, 1425–1434 (2004).
pubmed: 15039230 pmcid: 1615329 doi: 10.1016/S0002-9440(10)63229-4
Levine, M. E. & Crimmins, E. M. Sarcopenic obesity and cognitive functioning: the mediating roles of insulin resistance and inflammation? Curr. Gerontol. Geriatr. Res. 2012, 826398 (2012).
pubmed: 22611388 pmcid: 3352243 doi: 10.1155/2012/826398
Jang, H. C. Sarcopenia, Frailty, and Diabetes in Older Adults. Diabetes Metab. J. 40, 182–189 (2016).
pubmed: 27098509 pmcid: 4929221 doi: 10.4093/dmj.2016.40.3.182
Wang, X., Hu, Z., Hu, J., Du, J. & Mitch, W. E. Insulin resistance accelerates muscle protein degradation: Activation of the ubiquitin-proteasome pathway by defects in muscle cell signalling. Endocrinol. 147, 4160–4168 (2006).
doi: 10.1210/en.2006-0251
Mullins, R. J., Diehl, T. C., Chia, C. W. & Kapogiannis, D. Insulin Resistance as a Link between Amyloid-Beta and Tau Pathologies in Alzheimer’s Disease. Front. Aging Neurosci. 9, 118 (2017).
pubmed: 28515688 pmcid: 5413582 doi: 10.3389/fnagi.2017.00118
Vedovelli, K. et al. Multimodal physical activity increases brain-derived neutrophic factor levels and improves cognition in institutionalized older women. GeroScience 39, 406–417 (2017).
doi: 10.1007/s11357-017-9987-5
Chen, S. et al. Physical Frailty Is Associated with Longitudinal Decline in Global Cognitive Function in Non-Demented Older Adults: A Prospective Study. J. Nutr. Health Aging 22, 82–88 (2018).
pubmed: 29300426 doi: 10.1007/s12603-017-0924-1 pmcid: 29300426
Feng, L. et al. Physical Frailty, Cognitive Impairment, and the Risk of Neurocognitive Disorder in the Singapore Longitudinal Ageing Studies. J. Gerontol. A Biol. Sci. Med. Sci 72, 369–375 (2017).
pubmed: 27013397 pmcid: 27013397
Robertson, D. A., Savva, G. M. & Kenny, R. A. Frailty and cognitive impairment–a review of the evidence and causal mechanisms. Ageing Res. Rev. 12, 840–851 (2013).
pubmed: 23831959 doi: 10.1016/j.arr.2013.06.004 pmcid: 23831959
Yu, R. et al. The Effects of Combinations of Cognitive Impairment and Pre-frailty on Adverse Outcomes from a Prospective Community-Based Cohort Study of Older Chinese People. Front. Med. 5, 50, https://doi.org/10.3389/fmed.2018.00050 (2018).
doi: 10.3389/fmed.2018.00050
Robertson, D. A., Savva, G. M., Coen, R. F. & Kenny, R. A. Cognitive function in the prefrailty and frailty syndrome. J. Am. Geriatr. Soc. 62, 2118–2124 (2014).
pubmed: 25370593 doi: 10.1111/jgs.13111 pmcid: 25370593
Rosado-Artalejo, C. et al. Cognitive Performance across 3 Frailty Phenotypes: Toledo Study for Healthy Aging. J. Am. Med. Dir. Assoc. 18, 785–790 (2017).
pubmed: 28623151 doi: 10.1016/j.jamda.2017.04.008 pmcid: 28623151
Sleight, C. & Holtzer, R. Differential associations of functional and cognitive health outcomes with pre-frailty and frailty states in community-dwelling older adults. J Health Psychol, 1359105317745964. https://doi.org/10.1177/1359105317745964 (2017)
Alcorn, T. et al. Cross-sectional associations between metabolic syndrome and performance across cognitive domains: A systematic review. Appl. Neuropsychol. Adult 26, 186–199 (2019).
pubmed: 28945138 doi: 10.1080/23279095.2017.1363039 pmcid: 28945138
Janssen, I., Heymsfield, S. B., Baumgartner, R. N. & Ross, R. Estimation of skeletal muscle mass by bioelectrical impedance analysis. J. Appl. Physiol. 89, 465–471 (2000).
pubmed: 10926627 pmcid: 10926627 doi: 10.1152/jappl.2000.89.2.465
Moreira, M. A. et al. Sarcopenic obesity and physical performance in middle aged women: a cross-sectional study in Northeast Brazil. BMC Public. Health 16, 43, https://doi.org/10.1186/s12889-015-2667-4 (2016).
doi: 10.1186/s12889-015-2667-4 pubmed: 26775160 pmcid: 4715318
Ruiz, J.R. et al. Objectively measured sedentary time and physical activity in women with fibromyalgia: a cross-sectional study. BMJ Open 3 (2013).
pubmed: 23794573 pmcid: 3686217 doi: 10.1136/bmjopen-2013-002722
Moh, A. et al. Excess visceral adiposity is associated with diabetic retinopathy in a multiethnic Asian cohort with longstanding type 2 diabetes. Endocr. Res. 43, 186–194 (2018).
pubmed: 29624091 doi: 10.1080/07435800.2018.1451541 pmcid: 29624091
Moh, M. C. et al. Evaluation of body adiposity index as a predictor of aortic stiffness in multi-ethnic Asian population with type 2 diabetes. Diab Vasc. Dis. Res. 12, 111–118 (2015).
pubmed: 25491287 doi: 10.1177/1479164114554609 pmcid: 25491287

Auteurs

Serena Low (S)

Diabetes Centre, Admiralty Medical Centre, Singapore, Block 676, Level 4, Kampung Admiralty, Woodlands Drive 71, Singapore, 730676, Singapore.
Clinical Research Unit, Khoo Teck Puat Hospital, 90 Yishun Central, Singapore, 768828, Singapore.

Tze Pin Ng (TP)

Gerontology Research Programme, Department of Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore, National University Health System Tower Block, Level 9, 1E Kent Ridge Road, Singapore, 119228, Singapore.

Chin Leong Lim (CL)

Lee Kong Chian School of Medicine, Nanyang Technological University, Clinical Sciences Building, 11 Mandalay Road, Singapore, 308232, Singapore.

Angela Moh (A)

Clinical Research Unit, Khoo Teck Puat Hospital, 90 Yishun Central, Singapore, 768828, Singapore.

Su Fen Ang (SF)

Clinical Research Unit, Khoo Teck Puat Hospital, 90 Yishun Central, Singapore, 768828, Singapore.

Jiexun Wang (J)

Clinical Research Unit, Khoo Teck Puat Hospital, 90 Yishun Central, Singapore, 768828, Singapore.

Kiat Sern Goh (KS)

Department of Geriatrics, Changi General Hospital, Singapore, 2 Simei Street 3, Singapore, 529889, Singapore.

Keven Ang (K)

Clinical Research Unit, Khoo Teck Puat Hospital, 90 Yishun Central, Singapore, 768828, Singapore.

Wern Ee Tang (WE)

National Healthcare Group Polyclinics, Singapore, 3 Fusionopolis Link, Nexus@one-north, South Tower, Singapore, 138543, Singapore.

Pek Yee Kwan (PY)

National Healthcare Group Polyclinics, Singapore, 3 Fusionopolis Link, Nexus@one-north, South Tower, Singapore, 138543, Singapore.

Tavintharan Subramaniam (T)

Diabetes Centre, Admiralty Medical Centre, Singapore, Block 676, Level 4, Kampung Admiralty, Woodlands Drive 71, Singapore, 730676, Singapore.

Chee Fang Sum (CF)

Diabetes Centre, Admiralty Medical Centre, Singapore, Block 676, Level 4, Kampung Admiralty, Woodlands Drive 71, Singapore, 730676, Singapore.

Su Chi Lim (SC)

Diabetes Centre, Admiralty Medical Centre, Singapore, Block 676, Level 4, Kampung Admiralty, Woodlands Drive 71, Singapore, 730676, Singapore. lim.su.chi@ktph.com.sg.
Clinical Research Unit, Khoo Teck Puat Hospital, 90 Yishun Central, Singapore, 768828, Singapore. lim.su.chi@ktph.com.sg.
Saw Swee Hock School of Public Health, National University of Singapore, 12 Science Drive 2, #10-01, Singapore, 117549, Singapore. lim.su.chi@ktph.com.sg.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH